The polymorphism of the angiotensin-converting enzyme gene is considered to be associated with increased risk for stroke, but there is a diversity in the results obtained. The genetic involvement of the renin-angiotensin system in stroke also remains unclear. To predict the genetic risk of lacunar infarction, we conducted an association study in an Ohasama population, which is the cohort in a rural region of northern Japan. A total of 134 subjects without major neurological, cardiovascular, or metabolic disorders were recruited. Using brain magnetic resonance imaging, the number of lacunae in each of four brain regions were calculated, and periventricular hyperintensity was classified into five grades. We used the following four candidate gene polymorphisms: angiotensin converting enzyme (ACE)/Insertion(I)-Deletion(D), angiotensinogen (AGT)/M235T, angiotensin II type 1 receptor (AT 1 )/ A1166C, type 2 receptor (AT 2 )/C3123A, to examine the association between polymorphisms and the severity of lacunar infarction.
T he real causes in the majority of patients with cerebrovascular disease (CVD) remains uncertain, even though some rare metabolic and coagulation abnormalities predisposing to stroke are known. Although the pathogenic determinants of hypertension and atherosclerosis are the prediction of CVD because hypertension and atherosclerosis are major risks for stroke, genetic factors must be focused on what may act either independently, as a risk for CVD, or by modulating the effect of classical risk factors. 1, 2 The renin-angiotensin (R-A) system potentially contains etiologic candidate genes for causing cerebrovascular and cardiovascular diseases. The R-A system is involved in vasoconstriction, regulation of electrolyte balance, and vascular remodeling. The insertion (I)-deletion (D) polymorphism in intron 16 of the angiotensin converting enzyme (ACE) gene was associated with the level of circulating ACE concentration, [3] [4] [5] [6] and with increased risk of myocardial infarction 5, [7] [8] [9] [10] and idiopathic dilated cardiomyopathy, 11 independent of conventional risk factors. Some reports showed that the ACE gene was associated with stroke in humans and the D allele was an independent risk factor for CVD, [12] [13] [14] but contradicting reports have also been published by other groups. 15, 16 On the other hand, there have been only a few reports on the association between other components of the R-A system and CVD. The angiotensinogen (AGT) gene contains several base substitutions that are related to serum AGT concentration, 17, 18 and polymorphisms that have been associated with hypertension and myocardial infarction. [17] [18] [19] [20] [21] [22] [23] Several reports showed that angiotensin II type 1 receptor (AT 1 ) gene polymorphism also is associated with hypertension and myocardial infarction, but the genetic involvement of angiotensin II type 2 receptor (AT 2 ) gene polymorphism has not yet been examined. 24, 25 The aim of this study was to determine whether the gene polymorphisms not only of ACE, but also of AGT, AT 1 , and AT 2 are associated with CVD. We therefore performed an association study using the Japanese population in Ohasama, Iwate Prefecture, Japan. We have been monitoring ambulatory blood pressure (BP), home BP, and mortality in this rural Japanese community since 1987. 26, 27 In this population, home BP and ambulatory BP had a stronger predictive power for mortality than casual screening BP, 28, 29 and the mortality risk was the highest in the subjects with the nocturnal BP type called the inverted dipper. 30 Furthermore, an excessive fall in nocturnal BP was associated with ischemic silent cerebrovascular lesions in elderly women. 31 The present study is the first report to examine the association between the silent cerebrovascular ischemia and these four gene polymorphisms in the R-A system. This study might provide a better understanding of genetic risk factors for early state of CVD.
MATERIALS AND METHODS

Subjects
The total population of this study was 134 subjects (40 men and 94 women). They were recruited for the Ohasama Study, which was approved by the Institutional Review Board of the Tohoku University School of Medicine ( Table 1 ). All of the subjects were between the ages of 51 and 70 years, and gave informed consent. Detailed medical histories and risk factors for stroke were ascertained for each subject. Patients with major neurological, cardiovascular, or metabolic disorders (eg, hyperlipidemia, diabetes mellitus) were excluded. Hypertensive patients taking antihypertensive drugs were also excluded to avoid the influence of medication.
Blood Pressure Measurement Physicians initially measured each subject's blood pressure three times consecutively after the subjects were seated for Ն2 min. Standard mercury sphygmomanometers were used for measurements.
Magnetic Resonance Imaging (MRI)
The MRI was performed with a superconducting magnet that had a main field strength of 0.5 T (Toshiba 50-A). The brains of all participants were imaged in the axial plane in 10-mm-thick slices. T 1 -weighted images were obtained using a short spin-echo sequence with a repetition time of 50 msec and an echo time of 20 msec. T 2 -weighted images were obtained using a long spinecho pulse sequence with a repetition time of 2,000 msec and an echo time of 120 msec. The matrix was 256 ϫ 256 pixels.
The images were evaluated in a blinded manner by two physicians who determined the number of lacunae and the extent of periventricular signal abnormalities. A lacuna was defined as an area of low signal intensity that measured Ͻ10 mm and Ͼ3 mm on T 1 -weighted images and was visible as a hyperintense lesion on T 2 -weighted images. Hyperintense punctuate lesions present only on the T 2 -weighted images were not counted as lacunae, to exclude small unidentified bright objects of little clinical significance. Lesions that measured Ͻ3 mm on the T 1 -as well as the T 2 -weighted images were excluded to avoid the inclusion of enlarged perivascular spaces. Periventricular hyperintensity (PVH) observed on T 2 -weighted images was classified into five grades. When PVH was observed only in the region adjoining the lateral ventricle, it was scored as one point. When PVH was observed in the entire region from the lateral ventricle to the cortex, it was scored as two points. The frontal and occipital scores were summed, resulting in scores that ranged from grade 0 to 4 (ie, no points, grade 0; one point, grade 1; two points, grade 2; three points, grade 3; and four points, grade 4).
DNA Extraction and Genotyping
DNA of all participants was extracted from 200-L of buffy coat using QIAamp Kit (QIAGEN Inc, Valencia, CA). The polymorphisms of AGT, AT 1 , and AT 2 genes were identified using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The ACE polymorphism was determined only by PCR and agarose gel electrophoresis. To avoid the false determination of ACE/ID polymorphism, I allele specific amplification was carried out following the protocol of Lindpaintner et al. 32 AGT, AT 1 , and AT 2 polymorphisms were determined by digestion of each PCR product with MspI, DdeI, and AluI, respectively. The digested products were visualized on 3% Sea Kem HGT agarose gel (FMC BioProducts, Rockland, ME) by ethidium bromide staining.
Statistical Analysis
The association between genotypes of candidate genes and the number of lacunae or PVH grade was analyzed using one-way analysis of variance (ANOVA). To assess the contribution of each genotype to them, excluding the influences of age, sex, and BP, we performed multiple logistic regression analysis using the computer software application JMP 3.0 (SAS Institute Inc, Cary, NC). A P value Ͻ .05 was accepted as statistically significant.
RESULTS
All subjects were divided into two subgroups according to their age: 51 to 60 years and 61 to 70 years. Blood pressure, age, and sex ratio in each subgroup are listed in Table 1 . No significant differences were detected between the younger and the older subgroup. Each gene polymorphism and its position are shown in Table 2 . The D/I (ACE) and M/T (AGT) allele frequencies in the present study were 0.33/0.67 and 0.16/0.84, respectively. The A/C (AT 1 ) and C/A (AT 2 ) allele frequencies in our subjects were 0.93/0.07 and 0.59/0.41, respectively. There were no subjects homozygous for MM (AGT) or CC (AT 1 ) in this population. There was no deviation in genotype frequencies from those predicted by the Hardy-Weinberg law.
In our Japanese population, AGT polymorphism was associated with the number of lacunae in the brain stem (P Ͻ .05), the basal ganglia (P Ͻ .05), and whole brain (P Ͻ .005) regions (Table 3 ). These positive associations were evident in both the older and total populations, though not in the younger population. However, AGT polymorphism was not associated with the number of lacunae in the other brain regions or with PVH in all subgroups. Interestingly, however, the number of lacunae was significantly lower in the subjects homozygous for TT (AGT) in both the older and total populations, contrary to what we had expected (Figure 1 ). The AT 1 polymorphism was associated with a number of lacunae in the basal ganglia (P Ͻ .05) and whole brain (P Ͻ .05) regions only in the younger population. Moreover, the AT 1 polymorphism was also associated with PVH grade in the younger population (P Ͻ .005) ( Table 4) . However, no association was detected between this polymorphism and the number of lacunae in the other brain regions and in the other two populations. The AC (AT 1 ) heterozygous subjects had more lacunae in the whole brain and a higher PVH grade than AA (AT 1 ) homozygotes (Figure 2 ). The results of multiple logistic regression analysis for AGT polymorphism demonstrated that AGT genotypes were associated with the number of lacunae in the whole brain, the basal ganglia, and the brain stem regions in the older and total population (Table 5 ). Moreover, AT 1 genotypes were associated with the number of lacunae in the whole brain and the basal ganglia as well as PVH grade in the younger population (Table 6 ). In contrast, neither the ACE nor the AT 2 polymorphisms were associated with the number of lacunae and with PVH grade, despite the fact that the ACE polymorphism has been shown to be associated with cerebral infarction in some previous reports.
DISCUSSION
The D-I (ACE) and M235T (AGT) polymorphisms are associated with higher serum ACE and AGT levels, [3] [4] [5] [6] 17, 18 and are reported to be associated with cardiovascular disease. [12] [13] [14] 23 Similarly, the AT 1 gene polymorphism was also reported to increase the risk of myocardial infarction although the mechanism is not clarified. 23, 24 Recent data indicate a relation of AT 1 genotypes to arterial stiffness, 33, 34 and ACE genotypes to intima-media thickness of the common carotid artery, although ACE genotypes were not associated with internal carotid artery stenosis. 12, 16 A major risk factor for lacunar infarction is hypertension. Previous studies have shown both the presence and the absence of a relationship between all the polymorphisms except AT 2 and hypertension. 6, 35, 36 Recently, some reports showed an association between lacunar infarction and ACE polymorphism, 12, 13 but other reports showed no association between ACE polymorphism and stroke. 14, 16 However, the relation between silent cerebrovascular ischemia and genetic risk factors has not been studied. In this study, the AGT polymorphism was associated with the number of lacunae in both the older and total populations, and AT 1 polymorphism was associated with the number of lacunae and PVH grade in the younger population. Although neither ACE nor AT 2 polymorphisms were associated with the number of lacunae and with PVH grade, our study does not contradict previous reports because we examined the association between genotypes and the grade of silent cerebrovascular ischemia, not the prevalence of lacunar infarction. The number of lacunae might reflect the severity of atherosclerotic change or microthrombosis in cerebral capillaries, and the number of lacunae in each cerebral region might reflect the sensitivity to the ischemic change of the capillaries feeding each cerebral region. Previous reports showed that the T allele of AGT gene and the C allele of AT 1 gene are risk factors for hypertension, 17, 25 suggesting the possibility that these alleles also enhance the risk for CVD. In the present study, however, the number of lacunae was significantly lower in TT (AGT) homozygotes than in MT (AGT) heterozygotes. This inconsistency results from the fact that almost all subjects were normotensive or borderline hypertensive because subjects receiving antihypertensive medication, who were regarded as severe hypertensive patients, were excluded. When the influence of severe hypertension is excluded, the M allele of AGT might be an independent risk for lacunar infarction. Consequently, the AGT polymorphism might have an effect on lacunar infarction through other mechanisms: for example, age, hemodynamic change in capillaries caused by atherosclerosis, and lipid metabolism. Angiotensinogen is a member of the serine protease inhibitor family (SERPIN), which also includes protein C inhibitor and antithrombin III, suggesting that AGT might also be involved in thrombogenesis. 37 , 38 Although we did not show direct evidence that AGT mutation predisposes to thrombosis in the present study, our results that the AGT polymorphism increases the risk of lacunar infarction independent of BP support this hypothesis.
In this study, C allele of AT 1 polymorphism increased the number of lacunae in the younger population, suggesting that AT 1 gene is related to silent cerebrovascular ischemia. A feasible explanation for this result is that C allele increases the risk of lacunar infarction via high blood pressure. However, the possibility that AT 1 polymorphism is involved in other unknown pathogeneses of CVD cannot be discarded. In addition, the small number of subjects resulted from the exclusion of the subjects with risk for stroke may give rise to false-negative or false-positive results. Larger population studies are necessary to determine the exact relationship between genotypes and lacunar infarction, and to compare the prevalence of the genotypes and the number of lacunae in the whole brain or each brain region in the subgroup with lacunar infarction, excluding the influence of blood pressure.
